Not just leukemia: CMV may protect against lymphoma recurrence after allogeneic transplant
Year: 2016
Type: article
Abstract: Malignant cells that survive conditioning regimens of allogeneic hematopoietic cell transplantation (HCT) can still be controlled or eliminated immunologically by the donor graft via graft-versus-t...
Authors: Jonathan U. Peled, Robert R. Jenq
Institution: Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2530930590
